trial · primary record
Upadacitinib
Severe Alopecia Areata
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 300 |
| Primary completion | 2032-03 |
| Primary endpoint | Percentage of Participants with the Achievement of Severity of Alopecia Tool (SALT) Score <= 20, defined as less than or equal to 20% scalp hair loss. |
| Registry ID | NCT07772492 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:47.111Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07772492
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.